Page last updated: 2024-08-24

3-iodobenzylguanidine and edotreotide

3-iodobenzylguanidine has been researched along with edotreotide in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grossman, AB; Kaltsas, GA; Mukherjee, JJ	1
Besse, IM; Bushnell, DL; Juweid, ME; Madsen, MT; Menda, Y; O'Dorisio, MS; O'Dorisio, T	1
Bushnell, D; Khanna, G; O'Dorisio, MS	1
Besse, IM; Bushnell, DL; Juweid, ME; Madsen, MT	1
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN	1

Reviews

3 review(s) available for 3-iodobenzylguanidine and edotreotide

Article	Year
The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12 Suppl 2 Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Octreotide; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Yttrium Radioisotopes	2001
Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children. Cancer metastasis reviews, 2008, Volume: 27, Issue:4 Topics: 3-Iodobenzylguanidine; Child; Diagnostic Imaging; Endocrine Gland Neoplasms; Humans; Neoplasms, Germ Cell and Embryonal; Nervous System Neoplasms; Octreotide; Radiopharmaceuticals	2008
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6 Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon	2013

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and edotreotide

Article	Year
Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:4 Topics: 3-Iodobenzylguanidine; Drug Therapy, Combination; Humans; Iodine Radioisotopes; Models, Biological; Neuroendocrine Tumors; Octreotide; Radiation Dosage; Radiopharmaceuticals; Yttrium Radioisotopes	2006
Modeling combined radiopharmaceutical therapy: a linear optimization framework. Technology in cancer research & treatment, 2009, Volume: 8, Issue:1 Topics: 3-Iodobenzylguanidine; Humans; Models, Theoretical; Neoplasms; Octreotide; Radiation Dosage; Radiopharmaceuticals	2009

Article

Year

Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:4

Topics: 3-Iodobenzylguanidine; Drug Therapy, Combination; Humans; Iodine Radioisotopes; Models, Biological; Neuroendocrine Tumors; Octreotide; Radiation Dosage; Radiopharmaceuticals; Yttrium Radioisotopes

2006

Modeling combined radiopharmaceutical therapy: a linear optimization framework.

Technology in cancer research & treatment, 2009, Volume: 8, Issue:1

Topics: 3-Iodobenzylguanidine; Humans; Models, Theoretical; Neoplasms; Octreotide; Radiation Dosage; Radiopharmaceuticals

2009